1. Home
  2. DXCM vs AVB Comparison

DXCM vs AVB Comparison

Compare DXCM & AVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • AVB
  • Stock Information
  • Founded
  • DXCM 1999
  • AVB 1978
  • Country
  • DXCM United States
  • AVB United States
  • Employees
  • DXCM N/A
  • AVB N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • AVB Real Estate Investment Trusts
  • Sector
  • DXCM Health Care
  • AVB Real Estate
  • Exchange
  • DXCM Nasdaq
  • AVB Nasdaq
  • Market Cap
  • DXCM 32.7B
  • AVB 29.5B
  • IPO Year
  • DXCM 2005
  • AVB 1994
  • Fundamental
  • Price
  • DXCM $84.67
  • AVB $205.47
  • Analyst Decision
  • DXCM Strong Buy
  • AVB Buy
  • Analyst Count
  • DXCM 18
  • AVB 14
  • Target Price
  • DXCM $98.11
  • AVB $238.36
  • AVG Volume (30 Days)
  • DXCM 4.5M
  • AVB 825.5K
  • Earning Date
  • DXCM 05-01-2025
  • AVB 04-30-2025
  • Dividend Yield
  • DXCM N/A
  • AVB 3.41%
  • EPS Growth
  • DXCM N/A
  • AVB 19.57
  • EPS
  • DXCM 1.33
  • AVB 8.03
  • Revenue
  • DXCM $4,148,000,000.00
  • AVB $2,998,359,000.00
  • Revenue This Year
  • DXCM $16.49
  • AVB $3.43
  • Revenue Next Year
  • DXCM $15.45
  • AVB $5.38
  • P/E Ratio
  • DXCM $63.58
  • AVB $25.57
  • Revenue Growth
  • DXCM 9.11
  • AVB 6.12
  • 52 Week Low
  • DXCM $57.52
  • AVB $180.40
  • 52 Week High
  • DXCM $132.26
  • AVB $239.29
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 70.90
  • AVB 47.96
  • Support Level
  • DXCM $78.55
  • AVB $206.98
  • Resistance Level
  • DXCM $85.74
  • AVB $209.67
  • Average True Range (ATR)
  • DXCM 2.68
  • AVB 3.73
  • MACD
  • DXCM 1.92
  • AVB 0.27
  • Stochastic Oscillator
  • DXCM 94.71
  • AVB 17.88

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About AVB AvalonBay Communities Inc.

AvalonBay Communities owns a portfolio of 289 apartment communities with over 87,000 units and is developing 17 additional properties with over 6,000 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.

Share on Social Networks: